This patented invention is an internet-based laboratory data management system that can be used to create protocols, collect and organize data, archive long-term records, and facilitate scientific collaboration among researchers.
Stanford investigators have found a mechanistic difference between p53's ability to induce responses to acute DNA damage (either apoptosis or cell cycle arrest) versus oncogenic stimuli.
This technology consists of a collection of 48 ALDH cDNA and genomic clones for various ALDH isozymes from Prof. Daria Mochly-RosenÍs lab. DNA fragments of various ALDH genomic and cDNA isozymes were obtained by either PCR, direct DNA synthesis, restriction enzyme digests.
Stanford University researchers have developed a microelectromechanical ring resonator structure that oscillates in an elongating/compressing or breathing mode.
Stanford researchers have developed a highly specific, tunable system to improve the safety, efficacy and deliverability of gene therapy vectors and other biological therapies.
Stanford scientists in Dr. Liqun Luo's laboratory have developed a patented method for site-directed somatic cell recombination and concurrent labeling of "knock in" cells.
Researchers in the laboratory of Michael Cleary at Stanford University have developed a mouse that lacks the transcription factor Pbx1. Pbx1 is a proto-oncogene that was originally discovered at the site of chromosomal translocations in pediatric acute leukemia.
This user interface enables a user to define tags within virtual tour applications that label objects in panoramic images and video – a process that has been very difficult to achieve prior to this invention.
The fosGFP Mouse was created to address a fundamental question in neuroscience and physiology: following a behavioral task or exposure to a drug, what are the changes in physiological properties of activated neurons and cells?
Rat monoclonal antibody isotype IgG2a (clone #153) recognizes the HA peptide sequence [YPYDVPDYA] derived from the influenza hemagglutinin protein. The HA peptide can be added to unrelated proteins through recombinant techniques.